Skip to content

Clinical trials

Phase 4 Hemorrhage trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 4 Country / region: Norway Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20191
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Helsinki University Central Hospital2
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz1
Oslo University Hospital1
St. Olavs Hospital1
Vestre Viken Hospital Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage6
Acute Coronary Syndrome1
Blood Loss, Surgical1
Diabetes Insipidus1
Infarction1
Infections1
Liver Neoplasms1
Myocardial Infarction1
Pancreatic Neoplasms1
Postoperative Hemorrhage1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.